Fetal Care Center of Cincinnati
David F. Lewis, MD, MBA
Title
Professor and Vice Chair, Obstetrics
Director, Maternal-Fetal Medicine Fellowship Program at The University of Cincinnati
Maternal-Fetal Medicine, Fetal Care Center of Cincinnati
Appointment
Professor of Obstetrics, University of Cincinnati College of Medicine
Bio
David F. Lewis, MD, finished medical school at Louisiana State University in 1985. He finished his residency in Obstetrics and Gynecology at LSU Health Sciences Center in Shreveport, LA in 1989 and his fellowship in Maternal-Fetal Medicine at the University of California, Irvine in 1991. He began his academic career back at LSU by starting Perinatal Services at that institution. Over his 20 year career, he has been Residency Program Director at the University of Kentucky and Professor and Chairman of Obstetrics and Gynecology at Louisiana State University School of Medicine from 2002-2007.
Dr. Lewis joined the faculty at the University of Cincinnati in the Department of Obstetrics and Gynecology in November, 2007 as Professor and Vice Chair of Obstetrics and Director of the Maternal-Fetal Medicine Fellowship.
Credentials
BS: Biological Sciences, Louisiana State University 1981
MD: Louisiana State University 1985
MBA: Business Administration, University of Kentucky 2002
Residency: LSU Health Sciences Center 1985-1989
Fellowship: Maternal-Fetal Medicine, University of California, Irvine 1989-1991
Research
Dr. Lewis has been very active with research with over 90 Peer Review publications. His interests include preterm, premature rupture of membranes, preeclampsia and prematurity.
Publications, Most Recent
O’Brien JM, Lewis DF. Progestins for the prevention of preterm birth. OB/GYN Surgery 2008.
O’Brien JM, Adair CD, Lewis DF, Hall DR, et al. Progesterone vaginal gel for the reduction of recurrent preterm birth: primary results from a randomized, double-blind, placebo-controlled trial.Ultra Obstet Gynecol 2007; 30:687-696.
DeFranco EA, O’Brien JM, Adair CD, Lewis DF, et al. Vaginal progesterone is associated with a decrease in risk for early preterm birth and improved neonatal outcome in women with a short cervix: a secondary analysis from a randomized, double-blind, placebo-controlled trial.Ultra Obstet Gynecol 2007;30:697-705.
Barrilleaux PS, Magann EF, Chauhan SP, York BM, Philibert L, Lewis DF. Amniotic fluid index as a predictor of adverse perinatal outcome in the HELLP syndrome.J Reprod Med 2007;52:293-8.
Ibrahim H, Masood SA, Chen E, Tice H, Julian KC, Lewis DF. Sangster G. Agnathia-Otocephaly. J Perinat, 2007.
Wang Y, GU Y, Lewis DF. Gene expresión profiles in leukocytes from women with normal pregnancy and preeclampsia. Am J Obstet Gynecol, 2007.
Masciocchi M, Zhang J, Sun W, Liu A, Lewis DF, Wang Y. Placental genetic polymorphisms and preeclampsia.Placenta, 2007.
Ibrahim H, Lewis D, Harrison GK, Tice H, Sangster G. Congenital Ovarian Cyst.J Perinat. In press, 2007
Wang Y, Lewis DF, Alexander SJ, Grangier DN. Endothelial barrier function in preeclampsia.Front Biosci, 2007;12:2412-24.
Wang Y, Lewis DF, Zhang Y, et. Al. Enhanced P-selectin immunoreactivity in the maternal vessel endothelium and elevated plasma soluble P-selectin levels in women with preeclampsia. NCEM January, 2007.
Lewis DF, Jaekle FK, Robichaux AG, Canzoneri BJ, Horton K, Salas A. Expectantly managed non-vertex preterm PROM: What are the risks? Am J Obstet Gynecol 2007;196:566.e1-566.e6.
Gu Y, Zhang Y, Lewis DF, Groome LJ, Wang Y. Increased superoxide generation and decreased stress protein Hsp90 expression in human umbilical cord vein endothelial cells (HUVECs) from pregnancies complicated by preeclampsia. Hypertens Pregn 2006;25:169-82.
Zhang Y, Gu Y, Lewis DF. Wang. Reduced cellular glutathione reductase activity and increased adhesion molecule expression in endothelial cells cultured with maternal plasma from women with preeclampsia.J Soc Gynecol Investig 2006;13:412-17.
Cormier CM, Canzoneri BJ, Lewis DF, Briery C, Knoepp L, Mailhes JB. Urolithiasis in pregnancy: current diagnosis, treatment and pregnancy complications. Ob Gyn Surv. 2006;61:733-41.
Cormier CM, Lucas M, Philibert L, Lewis D. A Randomized trial of ketoralac tromethamine versus hydrocodone for treatment of pain after vaginal delivery. J Repro Med, 2006.
Potluri V, Lewis D, Burton GV. Chemotherapy with taxanes in breast cancer during pregnancy: case report and review of the literature. Clin Breast Cancer 2006:6:167-70.
Wang Y, Gu Y, Zhang Y, Lewis DF, Alexander JS, Granger DN. Increased chymotrypsin-like protease (chymase) expression and activity in placentas from women with preeclampsia.Placenta, 2006; in print.
GU B, Alexander JS, Gu Y, Zhang Y, Lewis DF, Wang Y. Expression of lymphatic vascular endothelial hyaluronan receptor-1 (LYVE-1) in the human placenta. Lymphat Res Biol, 2006;4:11-7.
